Medplus Health Services Ltd

Medplus Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Medplus Health Services Ltd

₹ 834 -1.07%
14 Jan - close price
medplusindia.com BSE: 543427 NSE: MEDPLUS
About
Key Points

India's Leading Pharmacy Company[1][2]
MedPlus is the 2nd largest pharmacy retailer in India, with 4,930 stores across 13 states and 1 union territory, serving 750 cities as of Q2 FY26. These stores are strategically distributed to maintain a high presence in metro, tier-one, and tier-two cities.

  • Store Distribution by Region[2]
  • Telangana: 781 stores
  • Andhra Pradesh: 569 stores
  • Karnataka: 997 stores
  • Tamil Nadu: 1014 stores
  • West Bengal: 691 stores
  • Maharashtra: 587 stores
  • Odisha: 179 stores
  • Chhattisgarh: 45 stores
  • Madhya Pradesh: 33 stores
  • Puducherry: 5 stores
  • Delhi: 1 store
    They added 218 net new stores in H1 FY2026, of which 121 were in Tier-2 and Tier-3 cities. 28 stores were closed in Q2 FY26, out of which 13 closed due to relocation, 5 closed due to franchisee withdrawal, 10 closed due to other reasons.[3][4]
Website BSE NSE
  • Market Cap ₹ 9,997 Cr.
  • Current Price ₹ 834
  • High / Low ₹ 1,052 / 603
  • Stock P/E 190
  • Book Value ₹ 106
  • Dividend Yield 0.00 %
  • ROCE 4.58 %
  • ROE 3.32 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 29.4% CAGR over last 5 years
  • Company's median sales growth is 46.8% of last 10 years

Cons

  • Stock is trading at 7.83 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 1.57% over last 3 years.
  • Promoters have pledged or encumbered 59.3% of their holding.
  • Working capital days have increased from 53.4 days to 76.5 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Retailing Pharmacy Retail

Part of BSE 500 BSE SmallCap BSE Allcap BSE Consumer Discretionary BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
42 57 87 72 99 148 148 178 156 177 202 184 206
43 54 76 70 92 137 135 160 139 158 178 160 179
Operating Profit -0 4 11 2 6 11 13 18 17 19 24 24 27
OPM % -1% 7% 13% 3% 6% 7% 9% 10% 11% 11% 12% 13% 13%
4 4 3 2 2 2 2 2 2 2 3 3 3
Interest 1 2 2 2 2 2 2 2 2 2 2 2 2
Depreciation 3 4 5 6 6 6 6 6 7 6 7 7 7
Profit before tax -1 2 7 -3 -0 4 6 12 10 12 18 18 21
Tax % 0% 65% 13% 0% 0% 25% -57% 20% 20% 22% 22% 23% 24%
-1 1 6 -3 -0 3 10 9 8 9 14 14 16
EPS in Rs -0.07 0.05 0.48 -0.29 -0.01 0.27 0.82 0.77 0.65 0.78 1.17 1.13 1.30
Raw PDF
Upcoming result date: 30 January 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
2 2 2 9 10 61 68 146 214 467 713 768
6 7 4 14 13 86 77 142 208 435 635 675
Operating Profit -3 -5 -2 -5 -3 -25 -9 3 6 32 78 94
OPM % -137% -225% -89% -52% -36% -41% -13% 2% 3% 7% 11% 12%
-1 1 0 1 1 2 2 10 23 7 9 10
Interest 1 0 0 12 0 0 1 3 7 8 9 9
Depreciation 0 0 0 0 0 1 1 5 15 24 27 27
Profit before tax -5 -4 -2 -16 -3 -24 -9 6 8 7 51 68
Tax % 0% 0% 0% 0% 0% 2% 0% 0% 27% -36% 21%
-5 -4 -2 -16 -3 -25 -9 6 6 9 40 53
EPS in Rs -292.30 -241.71 -109.61 -793.71 -126.23 -1,220.91 -186.95 0.47 0.46 0.79 3.37 4.38
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 77%
5 Years: 63%
3 Years: 70%
TTM: 22%
Compounded Profit Growth
10 Years: 30%
5 Years: 29%
3 Years: 95%
TTM: 75%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 10%
1 Year: 5%
Return on Equity
10 Years: 0%
5 Years: 1%
3 Years: 2%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.17 0.17 0.17 0.19 0.19 0.19 0.45 24 24 24 24 24
Reserves 126 108 88 185 185 395 517 1,089 1,117 1,164 1,216 1,252
55 55 55 0 0 3 7 44 86 89 95 101
6 21 39 3 6 17 24 30 45 33 65 52
Total Liabilities 187 185 183 189 192 415 548 1,187 1,272 1,310 1,399 1,430
1 1 0 0 0 7 23 85 179 192 184 184
CWIP 0 0 0 0 0 1 2 16 18 0 1 1
Investments 153 177 177 181 186 381 408 418 917 923 928 930
34 6 5 8 5 26 115 668 157 196 286 314
Total Assets 187 185 183 189 192 415 548 1,187 1,272 1,310 1,399 1,430

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-5 -4 -2 -1 -1 -0 -6 -18 11 8 47
-11 -24 0 -2 -3 -194 -15 -636 32 -24 -39
46 0 0 7 0 204 97 569 -8 -6 -10
Net Cash Flow 30 -28 -1 4 -4 10 76 -86 35 -22 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 32 29 14 22 80 51 62 53 64 54 62
Inventory Days 33 35 12 16 15 12
Days Payable 9 17 17 30 19 30
Cash Conversion Cycle 32 29 14 22 80 75 79 48 50 50 44
Working Capital Days -78 -72 -130 -97 -145 -12 -20 1,547 21 62 76
ROCE % -2% -1% -2% -1% -8% -2% 1% 1% 1% 5%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
40.43% 40.43% 40.43% 40.41% 40.45% 40.39% 40.39% 40.39% 40.39% 40.33% 40.32% 40.29%
3.94% 4.48% 4.87% 12.36% 12.96% 14.94% 14.85% 14.72% 15.23% 15.61% 16.43% 16.53%
28.77% 28.16% 28.13% 25.50% 25.19% 22.47% 22.17% 27.98% 25.66% 26.19% 26.03% 26.51%
26.56% 26.73% 26.42% 21.61% 21.31% 22.10% 22.51% 16.85% 18.68% 17.82% 17.18% 16.60%
0.29% 0.19% 0.15% 0.12% 0.10% 0.10% 0.08% 0.07% 0.05% 0.05% 0.05% 0.05%
No. of Shareholders 74,70273,51270,01766,43066,04874,97676,93487,32883,91283,43981,74278,337

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls